Hu, H., Li, H., Fang, X., Weng, S., Wang, K., Yuan, Y. (2026). Liposomal irinotecan (HR070803) plus fluorouracil and bevacizumab as second-line treatment in advanced colorectal cancer: Cohort A results from a phase 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.100